CN111449139A - Formula donkey milk powder containing N-acetylneuraminic acid - Google Patents
Formula donkey milk powder containing N-acetylneuraminic acid Download PDFInfo
- Publication number
- CN111449139A CN111449139A CN202010267448.5A CN202010267448A CN111449139A CN 111449139 A CN111449139 A CN 111449139A CN 202010267448 A CN202010267448 A CN 202010267448A CN 111449139 A CN111449139 A CN 111449139A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- donkey milk
- acetylneuraminic acid
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020250 donkey milk Nutrition 0.000 title claims abstract description 40
- 239000000843 powder Substances 0.000 title claims abstract description 30
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title claims abstract description 24
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 4
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 4
- -1 compound vitamin Chemical class 0.000 claims abstract description 4
- 239000005862 Whey Substances 0.000 claims abstract description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 3
- 229960003080 taurine Drugs 0.000 claims abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 15
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 7
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 6
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 6
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 6
- 239000002211 L-ascorbic acid Substances 0.000 claims description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 claims description 6
- 239000011706 ferric diphosphate Substances 0.000 claims description 6
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 6
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 6
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 6
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 6
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 6
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 6
- 229960000342 retinol acetate Drugs 0.000 claims description 6
- 239000011770 retinyl acetate Substances 0.000 claims description 6
- 235000019173 retinyl acetate Nutrition 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 229960001296 zinc oxide Drugs 0.000 claims description 2
- 235000014692 zinc oxide Nutrition 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 239000000126 substance Substances 0.000 description 10
- 230000003712 anti-aging effect Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000020256 human milk Nutrition 0.000 description 6
- 210000004251 human milk Anatomy 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 229940091258 selenium supplement Drugs 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 4
- 101800003838 Epidermal growth factor Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940116977 epidermal growth factor Drugs 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229940060155 neuac Drugs 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a formula donkey milk powder containing N-acetylneuraminic acid, which is prepared from the following raw materials in parts by weight: 90-100 parts of whole donkey milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 0.01-0.1 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral and 0.04-0.06 part of taurine. The invention has reasonable formula composition and comprehensive nutrition, and has the functions of improving immunity, increasing protein, prolonging life and the like.
Description
Technical Field
The invention relates to the technical field of food formulas, in particular to a formula donkey milk powder containing N-acetylneuraminic acid.
Background
With the continuous development and progress of society, people have more and more calls for the non-aging requirements of life bodies, and especially for middle-aged people, people face the fear of appearance of walking into the old, so that the old people continuously take corresponding anti-aging medicines and nutritional supplements, but the medicines have certain side effects, most of the components in the anti-aging medicines contain hormone medicines, and the long-term taking of the medicines can bring unexpected consequences to self health. Including vitamin c: the essential trace nutrient substances of the human body, however, after being taken excessively, the nutrient substances can not be absorbed by the human body, and then diarrhea can be generated, and cystine precipitation or oxalate calculus can be caused to be formed in the urinary tract; vitamin e (tocopherol): the composition is also an indispensable element for human bodies, has special effect on relieving human body aging, but can generate various non-specific discomforts when being taken in large dose (more than 100 mg per day) and for a long time; when the composition is used for more than 6 months, adverse reactions such as platelet aggregation, thrombosis and the like are easily caused. The daily dosage is more than 400 mg, and the chance of inducing thrombophlebitis is greatly increased when the medicine is taken for more than 1 year, especially when the medicine is taken together with estrogen. The donkey milk powder is prepared by the technologies of ultra-high pressure sterilization, freezing vacuum drying and the like after the donkey milk is dehydrated, so that the effective components in the fresh milk are completely reserved and are not damaged, and the effective nutrient components of the milk powder are ensured; chemical substances such as preservatives, additives and the like are not required to be added, so that the donkey milk powder is a pure natural food; the original state of color, fragrance and taste is completely retained, the taste is delicious and the mouthfeel is good, and the packaging is not required. The donkey milk is very similar to the human milk, the nutrient content of the donkey milk is almost 99 percent of the components contained in the human milk, and the donkey milk powder has the anti-aging effect on human bodies, so the donkey milk powder is the most ideal anti-aging nutrient for nourishing the face and keeping the young. Researches show that the donkey milk is very similar to human milk, is rich in functional whey protein and unsaturated fatty acid, and has unique functional effects of prolonging life, enhancing resistance and immunity, protecting liver and stomach, whitening skin and the like; tararinic acid contained in donkey milk can beautify and whiten skin; the donkey milk is rich in EGF (epidermal growth factor) which is internationally abbreviated as EGF, and the EGF has a miraculous effect of repairing nasal cavity tracheal mucosa and can enhance the resistance and the immunity of a human body; the tested donkey milk has the cholesterol content of only 1/5 of milk, belongs to natural organic food with low fat and low cholesterol, and is the first choice beverage for patients with diabetes and hypertension; donkey milk is a natural selenium-rich food, and the selenium content of the donkey milk is 5.2 times that of milk. Selenium is an indispensable substance for human development and growth, can stimulate the production of human immunoglobulin and antithromosome, eliminate substances adverse to human body, protect cell membrane and chromosome, and protect the structure and function of ribose and nucleic acid macromolecules. People can suffer from arteriosclerosis, myocardial infarction and hypertension due to selenium deficiency; selenium has physiological activity similar to that of trypsin in regulating sugar metabolism, preventing formation of peroxide free radicals, blocking metabolism of cancer cells and inhibiting division and growth of cancer cells; selenium can participate in the metabolism process of a human body, has multiple functions of improving immunity, increasing protein, prolonging life and the like, and can effectively relieve discomfort of women in menstrual period and climacteric period by drinking donkey milk. However, although donkey milk also contains active substances such as anti-aging and maintenance substances, the donkey milk contains less other necessary nutrient substances, is natural health-care milk, has inherent nutrition and efficacy, is small in quantity, and does not have donkey milk powder which can be industrially produced in the market at present, so that how to scientifically add auxiliary materials is realized, and the donkey milk powder which is rich in anti-aging is produced by adopting an advanced process technology.
Research shows that N-acetylneuraminic acid is called SA, NeuAc or NANA for short, is commonly called sialic acid or cubilose acid, and has a chemical molecular formula of C11H19NO9It is widely derived from breast milk and milk products, including human milk, cow milk, goat milk, etc., and has the highest content in breast milk colostrum. The industrial production process of the corn steep liquor is characterized in that food-grade glucose and corn steep liquor are taken as raw materials and are prepared by processes of fermentation, filtration, sterilization, hydrolysis, purification and the like of Escherichia coli (strain number SA-8). The N-acetylneuraminic acid can be combined with bacteria and viruses to achieve the effects of inhibiting and resisting through a certain mechanism. Meanwhile, the N-acetylneuraminic acid can regulate the anti-inflammatory activity of IgG, so that the effect of improving the immunity is achieved. N-acetylneuraminic acid has the functions of resisting bacteria and viruses and improving immunity, and is very important for human bodies. At present, no technical scheme related to the donkey milk powder with an anti-aging formula added with N-acetylneuraminic acid is disclosed.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the donkey milk powder containing the N-acetylneuraminic acid, and the donkey milk powder is beneficial to enhancing the immunity, resisting aging, maintaining, beautifying and whitening the skin.
In order to realize the purpose of the invention, the following technical scheme is adopted:
the formula donkey milk powder containing N-acetylneuraminic acid is prepared from the following raw materials in parts by weight: 90-100 parts of whole donkey milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 0.01-0.1 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral and 0.04-0.06 part of taurine.
Preferably, the compound vitamin is prepared from retinyl acetate, cholecalciferol, dl- α -tocopheryl acetate, pyridoxine hydrochloride, folic acid and L-ascorbic acid.
Preferably, the vitamin complex is prepared by mixing 0.3-0.6 part of retinyl acetate, 1.7-2 parts of cholecalciferol, 0.5-0.7 part of dl- α -tocopheryl acetate, 1.4-1.6 parts of pyridoxine hydrochloride, 0.4-0.6 part of folic acid and 0.40-0.52 part of L-ascorbic acid.
Preferably, the composite mineral is prepared from the following raw materials: ferric pyrophosphate, zinc oxide, sodium selenite and calcium carbonate.
Preferably, the compound mineral is prepared by mixing 0.4-0.6 part of ferric pyrophosphate, 0.35-0.45 part of zinc oxide, 0.3-0.5 part of sodium selenite and 0.6-08 part of calcium carbonate.
Compared with the prior art, the donkey milk is used as a main raw material, and the N-acetylneuraminic acid and vitamin A, vitamin D, vitamin E, vitamin B6, vitamin C, folic acid, calcium, iron, zinc and selenium which are necessary for a human body are added, so that the donkey milk has comprehensive nutrition in formula, and has multiple functions of improving immunity, increasing protein, prolonging life and the like.
Detailed Description
The technical solution of the present invention is further illustrated by the following examples.
Example 1
The formula donkey milk powder containing N-acetylneuraminic acid is prepared by mixing the following raw materials in parts by weight:
wherein the vitamin complex is prepared by mixing 0.3-0.6 part of retinyl acetate, 1.7-2 parts of cholecalciferol, 0.5-0.7 part of dl- α -tocopheryl acetate, 1.4-1.6 parts of pyridoxine hydrochloride, 0.4-0.6 part of folic acid and 0.40-0.52 part of L-ascorbic acid.
Wherein the compound mineral substance is formed by mixing 0.4-0.6 part of ferric pyrophosphate, 0.35-0.45 part of zinc oxide, 0.3-0.5 part of sodium selenite and 0.6-08 part of calcium carbonate.
The donkey milk powder prepared by mixing the raw materials has reasonable formula composition and comprehensive nutrition, and has multiple functions of improving immunity, increasing protein, prolonging life and the like.
Example 2
The formula donkey milk powder containing N-acetylneuraminic acid is prepared by mixing the following raw materials in parts by weight:
wherein the vitamin complex is prepared by mixing 0.3-0.6 part of retinyl acetate, 1.7-2 parts of cholecalciferol, 0.5-0.7 part of dl- α -tocopheryl acetate, 1.4-1.6 parts of pyridoxine hydrochloride, 0.4-0.6 part of folic acid and 0.40-0.52 part of L-ascorbic acid.
Wherein the compound mineral substance is formed by mixing 0.4-0.6 part of ferric pyrophosphate, 0.35-0.45 part of zinc oxide, 0.3-0.5 part of sodium selenite and 0.6-08 part of calcium carbonate.
The donkey milk powder prepared by mixing the raw materials has reasonable formula composition and comprehensive nutrition, and has multiple functions of improving immunity, increasing protein, prolonging life and the like.
Claims (5)
1. The formula donkey milk powder containing N-acetylneuraminic acid is prepared from the following raw materials in parts by weight: 90-100 parts of whole donkey milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 0.01-0.1 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral and 0.04-0.06 part of taurine.
2. The formula donkey milk powder containing N-acetylneuraminic acid according to claim 1, wherein the multivitamins are prepared from retinyl acetate, cholecalciferol, dl- α -tocopheryl acetate, pyridoxine hydrochloride, folic acid, L-ascorbic acid.
3. The formula donkey milk powder containing N-acetylneuraminic acid according to claim 1 or 2, wherein the vitamin complex is prepared by mixing 0.3-0.6 part of retinyl acetate, 1.7-2 parts of cholecalciferol, 0.5-0.7 part of dl- α -tocopheryl acetate, 1.4-1.6 parts of pyridoxine hydrochloride, 0.4-0.6 part of folic acid and 0.40-0.52 part of L-ascorbic acid.
4. The formulated donkey milk powder containing N-acetylneuraminic acid according to claim 1, wherein the compound mineral is prepared from the following raw materials: ferric pyrophosphate, zinc oxide, sodium selenite and calcium carbonate.
5. The formulated donkey milk powder containing N-acetylneuraminic acid according to claim 1 or 4, wherein the compound minerals are prepared by mixing 0.4-0.6 part of ferric pyrophosphate, 0.35-0.45 part of zinc oxide, 0.3-0.5 part of sodium selenite and 0.6-08 parts of calcium carbonate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010267448.5A CN111449139A (en) | 2020-04-08 | 2020-04-08 | Formula donkey milk powder containing N-acetylneuraminic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010267448.5A CN111449139A (en) | 2020-04-08 | 2020-04-08 | Formula donkey milk powder containing N-acetylneuraminic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111449139A true CN111449139A (en) | 2020-07-28 |
Family
ID=71671983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010267448.5A Pending CN111449139A (en) | 2020-04-08 | 2020-04-08 | Formula donkey milk powder containing N-acetylneuraminic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111449139A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61152233A (en) * | 1984-12-26 | 1986-07-10 | Snow Brand Milk Prod Co Ltd | Powdered milk blended with sialic acid |
| CN101695316A (en) * | 2009-11-11 | 2010-04-21 | 天津商业大学 | Milk powder with function of strengthening immunity and production method thereof |
| CN102429031A (en) * | 2011-11-01 | 2012-05-02 | 张明 | Method for producing freeze-dried whole donkey milk powder |
| EP2617290A1 (en) * | 2012-01-19 | 2013-07-24 | Konstantinos Petrotos | Plain, flavored or nutritionally fortified donkey milk powders and an integrated method for the production there of |
| CN103651856A (en) * | 2013-12-06 | 2014-03-26 | 巴里坤县花麒奶业有限责任公司 | Production technology for donkey milk powder |
| CN103734338A (en) * | 2013-12-18 | 2014-04-23 | 南昌大学 | Compounded donkey milk powder for improving immunity |
| CN104872286A (en) * | 2015-06-04 | 2015-09-02 | 南京贝杉国际贸易有限公司 | Comprehensive-nutrition formula donkey milk powder with function of protecting heart and brain for middle-aged and old people and preparation method thereof |
| CN106259957A (en) * | 2016-08-28 | 2017-01-04 | 新疆玉昆仑天然食品工程有限公司 | A kind of lyophilizing donkey milk powder and preparation method thereof |
| CN109007037A (en) * | 2018-10-16 | 2018-12-18 | 北京斯利安药业有限公司 | A kind of composition and products thereof enhancing infant immunity and application |
| CN110024869A (en) * | 2019-05-29 | 2019-07-19 | 湖北咸宁向阳湖兴兴奶业有限公司 | A kind of probiotics fruit sheep milk powder |
-
2020
- 2020-04-08 CN CN202010267448.5A patent/CN111449139A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61152233A (en) * | 1984-12-26 | 1986-07-10 | Snow Brand Milk Prod Co Ltd | Powdered milk blended with sialic acid |
| CN101695316A (en) * | 2009-11-11 | 2010-04-21 | 天津商业大学 | Milk powder with function of strengthening immunity and production method thereof |
| CN102429031A (en) * | 2011-11-01 | 2012-05-02 | 张明 | Method for producing freeze-dried whole donkey milk powder |
| EP2617290A1 (en) * | 2012-01-19 | 2013-07-24 | Konstantinos Petrotos | Plain, flavored or nutritionally fortified donkey milk powders and an integrated method for the production there of |
| CN103651856A (en) * | 2013-12-06 | 2014-03-26 | 巴里坤县花麒奶业有限责任公司 | Production technology for donkey milk powder |
| CN103734338A (en) * | 2013-12-18 | 2014-04-23 | 南昌大学 | Compounded donkey milk powder for improving immunity |
| CN104872286A (en) * | 2015-06-04 | 2015-09-02 | 南京贝杉国际贸易有限公司 | Comprehensive-nutrition formula donkey milk powder with function of protecting heart and brain for middle-aged and old people and preparation method thereof |
| CN106259957A (en) * | 2016-08-28 | 2017-01-04 | 新疆玉昆仑天然食品工程有限公司 | A kind of lyophilizing donkey milk powder and preparation method thereof |
| CN109007037A (en) * | 2018-10-16 | 2018-12-18 | 北京斯利安药业有限公司 | A kind of composition and products thereof enhancing infant immunity and application |
| CN110024869A (en) * | 2019-05-29 | 2019-07-19 | 湖北咸宁向阳湖兴兴奶业有限公司 | A kind of probiotics fruit sheep milk powder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eliseeva et al. | Vitamin C (ascorbic acid)–description, benefits and where it is found | |
| US6262019B1 (en) | Method of treatment of glutathione deficient mammals | |
| CN1275534C (en) | Corn peptide beverage and its processing method | |
| CN108157953A (en) | A kind of full nutrition formula food and preparation method thereof | |
| CN113412862A (en) | Formula milk powder for middle-aged and old people and preparation method thereof | |
| CN106993788A (en) | All Pure Nature royal jelly lozenge and preparation method thereof | |
| KR20020006114A (en) | Manufacturing Method of Absorptive Zinc-Oligopeptide in The Human Body | |
| CN103653113A (en) | Sea-buckthorn beverage | |
| US20100166796A1 (en) | Method of increasing cellular function and health of glutathione deficient animals | |
| CN111264622A (en) | Infant formula goat milk powder containing N-acetylneuraminic acid | |
| CN112385843A (en) | Balanced nutrition powder containing composite prebiotics and preparation method thereof | |
| CN102125196A (en) | Bee product formulation | |
| CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
| CN111449139A (en) | Formula donkey milk powder containing N-acetylneuraminic acid | |
| KR20020011594A (en) | Process for the prepartion of the foods on capsule thereof containing functional additives of a chondroition, glucosamin and ageilc utilis powder | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN107006864B (en) | Polypeptide resveratrol preparation, preparation method and application thereof, and health-care product or pharmaceutical composition containing polypeptide resveratrol preparation | |
| CN115702654A (en) | Middle-aged and old-aged modified goat milk powder assisting in reducing blood sugar and preparation method thereof | |
| CN102511815A (en) | Selenium-enriched oral solution and preparation method thereof | |
| CN113115941A (en) | Anti-inflammatory dietary therapy formula for improving cardiovascular and cerebrovascular diseases and regulating blood sugar and blood in body | |
| KR100734944B1 (en) | Functional food-composition with calcium lactate and rice bran | |
| JP5311760B2 (en) | Whitening agent | |
| CN116035213A (en) | Optimized diet therapy formula of plant organic nano selenium for activating immune system, preventing cancers and tumors, resisting oxidation and aging | |
| CN101311258A (en) | Aloe-medlar health-care wine | |
| CN101258935A (en) | Health-care spirulina food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 310000 room 1103-04, building 2, No. 371, Mingxing Road, Xiaoshan Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province Applicant after: Hangzhou jishuo Network Technology Co.,Ltd. Address before: 310000 room 1103-04, building 2, No. 371, Mingxing Road, Xiaoshan Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province Applicant before: Hangzhou Lianxing Trading Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200728 |
|
| RJ01 | Rejection of invention patent application after publication |